名老中医胡伟勇治疗慢性萎缩性胃炎学术经验与病案举隅
Academic Experience and Illustrative Cases of Famous Veteran TCM Doctor Hu Weiyong in Treating Chronic Atrophic Gastritis
DOI: 10.12677/tcm.2026.1510550, PDF,   
作者: 肖泽邦:江西中医药大学研究生院,江西 南昌;胡伟勇*, 熊 俊, 王根发, 余 婷, 宋采秋:南昌大学第二附属医院中医科,江西 南昌
关键词: 慢性萎缩性胃炎;脾胃虚弱;痞满;学术思想;临床经验;Chronic Atrophic Gastritis; Spleen-Stomach Deficiency; Stuffiness and Fullness; Academic Thoughts; Clinical Experience
摘要: 目的:本研究旨在总结名老中医胡伟勇主任治疗慢性萎缩性胃炎(CAG)的临床经验与学术思想,为中医诊治本病及学术传承提供临床参考。方法:采用理论溯源与临床经验归纳相结合的方法,梳理中医经典中CAG相关病机理论,系统整理胡伟勇主任的临证思路、核心治法、代表方剂及用药配伍规律,多维度归纳其完整诊疗体系。结果:胡师治疗CAG秉持“脾胃为先,化湿行气”核心思想,立足经典病机理论,活用四君子汤、二陈汤等经典方,并擅长随证加减药物,形成了从病机辨识、治则确立到方药施治的系统化诊疗特色,临床适用性极强。结论:胡伟勇主任诊治CAG的学术体系完善、用药特色鲜明,贴合本病核心病机,可有效指导临床辨证用药,为名老中医脾胃病学术传承、临床实践及后续研究提供临床参考。
Abstract: Objective: This study aims to summarize the clinical experience and academic thought of the renowned veteran Chinese medicine practitioner, Chief Physician Hu Weiyong, in treating chronic atrophic gastritis (CAG), so as to provide a clinical reference for the TCM diagnosis and treatment of this disease as well as for academic inheritance. Methods: By combining tracing theoretical origins with the summarization of clinical experience, this study systematically reviewed the pathogenesis theories related to CAG in Chinese medicine classics, organized Chief Physician Hu Weiyong’s clinical diagnostic and therapeutic thinking, core therapeutic methods, representative prescriptions, and medication compatibility patterns, and comprehensively summarized his complete diagnostic and therapeutic system from multiple dimensions. Results: In treating CAG, Dr. Hu adheres to the core concept of “prioritizing the spleen and stomach, resolving dampness, and promoting qi movement.” Grounded in classical pathogenesis theories, he flexibly applies classic formulas such as Sijunzi Decoction and Erchen Decoction, and excels at adding or removing medications based on syndrome differentiation. This has resulted in a systematic diagnostic and therapeutic approach encompassing pathogenesis identification, treatment principle establishment, and formula application, which demonstrates very strong clinical applicability. Conclusion: Hu’s academic system for diagnosing and treating CAG is well-established with distinctive medication characteristics. It aligns closely with the core pathogenesis of the disease and can effectively guide clinical syndrome differentiation and medication. This provides a clinical reference for the academic inheritance, clinical practice, and subsequent research of renowned veteran TCM practitioners specializing in spleen and stomach diseases.
文章引用:肖泽邦, 胡伟勇, 熊俊, 王根发, 余婷, 宋采秋. 名老中医胡伟勇治疗慢性萎缩性胃炎学术经验与病案举隅[J]. 中医学, 2026, 15(10): 243-250. https://doi.org/10.12677/tcm.2026.1510550

参考文献

[1] 房静远, 杜奕奇, 刘文忠, 等. 中国慢性胃炎诊治指南(2022年, 上海) [J]. 胃肠病学, 2023, 28(3): 149-180.
[2] 陈佳, 李守英, 徐红. 慢性萎缩性胃炎的研究进展[J]. 中国老年学杂志, 2013, 33(14): 3540-3542.
[3] 林刚. 治疗老年慢性萎缩性胃炎的体会[J]. 中医药学报, 2010, 8(3): 67-68.
[4] 高一心, 孙涛. 237例老年人胃癌癌前病变随访分析[J]. 肿瘤防治杂志, 2001, 8(2): 118-119.
[5] 魏玮, 杨洋. 慢性萎缩性胃炎诊治现状及中医药治疗优势[J]. 中医杂志, 2016, 57(1): 36-40.
[6] 付文婧, 王雨妍, 安彦军, 等. 基于“土郁夺之”理论探讨慢性萎缩性胃炎“炎癌转化”的病机与防治[J/OL]. 实用中医内科杂志, 1-6.
https://link.cnki.net/urlid/21.1187.R.20260228.1459.002, 2026-03-02.
[7] 曹元媛, 徐春凤. 中医经典名方治疗慢性萎缩性胃炎的研究[J]. 中药材, 2022, 45(4): 1015-1018.
[8] 杨洋, 瞿先侯, 杨敏, 等. 慢性萎缩性胃炎患者中医证候分型与癌变风险的相关性[J]. 中医杂志, 2020, 61(4): 319-324.
[9] 赵欢, 杨巧芳. 名中医治疗慢性萎缩性胃炎病因病机思路与用药规律[J]. 时珍国医国药, 2018, 29(6): 1518-1520.
[10] 安振涛, 奚肇宏, 严展鹏, 等. 慢性萎缩性胃炎中医证候规范化与客观化研究进展[J]. 中国中西医结合消化杂志, 2020, 28(3): 234-237.
[11] 白建英, 康立英, 张秀芬, 等. 探讨《脾胃论》中李东垣的“脾胃观” [J]. 中华中医药杂志, 2018, 33(4): 1478-1480.
[12] Nomura, A., Grove, J.S., Stemmermann, G.N., et al. (1990) A Prospective Study of Stomach Cancer and Its Relation to Diet, Cigarettes, and Alcohol Consumption. Cancer Research, 50, 627-631.
[13] Gao, Q.Y., Wang, Z., Chooi, E.Y.H., Cui, Y., Hu, Y., Yang, C., et al. (2012) A Novel Model Might Predict the Risk of Chronic Atrophic Gastritis: A Multicenter Prospective Study in China. Scandinavian Journal of Gastroenterology, 47, 509-517.
https://doi.org/10.3109/00365521.2012.658857
[14] 张效科, 丁纪茹, 周强, 等. 叶天士治疗脾胃病学术思想浅析[J]. 陕西中医药大学学报, 2020, 43(3): 42-45+68.
[15] 姜宁, 黄宣, 范一宏, 等. 中西医结合治疗胃癌前病变疗效的系统评价[J]. 中华中医药学刊, 2015, 24(1): 149-154.
[16] 高静彤, 刘智博, 李晓民, 等. “调和致中”学术思想源流及治疗脾胃类疾病探赜[J]. 上海针灸杂志, 2026, 45(5): 557-562.
[17] 吕苑. 四君子汤的药理研究和临床应用[J]. 中医研究, 2012, 25(1): 76-79.
[18] 高健, 吕邵娃. 人参化学成分及药理作用研究进展[J]. 中医药导报, 2021, 27(1): 127-130+137.
[19] 叶富强, 陈蔚文. 四君子汤对胃肠道作用的药理研究[J]. 时珍国医国药, 2005(1): 73-74.
[20] 包永生, 谢文英, 王俊月. 二陈汤研究进展[J]. 中国实验方剂学杂志, 2019, 25(23): 9-18.
[21] 王依明, 王秋红. 半夏的化学成分、药理作用及毒性研究进展[J]. 中国药房, 2020, 31(21): 2676-2682.
[22] 关徐涛, 杨鹤年, 张津铖, 等. 陈皮的化学成分和药理作用研究进展[J]. 中华中医药学刊, 2024, 42(6): 41-49+266.
[23] 谢诗晴, 王冬敏, 黄雪鑫, 等. 慢性胃炎活检组织病理学分级诊断存在的问题及分析[J]. 临床与实验病理学杂志, 2026, 42(5): 601-607.
[24] 王常松, 杨敏, 俞杰, 等. 人参丹参对萎缩性胃炎鼠模型胃黏膜保护及对 Bcl-xL、Bax、TLR4和NF-κB p65表达影响随机平行对照研究[J]. 实用中医内科杂志, 2012, 16(2): 19-20, 82.
[25] 吴时胜. 丹参对萎缩性胃炎伴异型增生的逆转治疗研究[J]. 时珍国医国药, 2002, 13(12): 751-752.